Stephen Davis, CEO: Acadia Pharmaceuticals ACAD Sell · Filed 24/08/20

Trade details

Type: Insider sale
Amount: $485,094.16
Shares · price: 31,747 sh · $15.28 a share
Held after: 186,555 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Stephen DavisCEO
Trade date: 24/08/19
Filed: 24/08/20
Days to filing: 1 days

Sold 14.5% of holdings

Share of holding sold: 14.5%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/07/20~24/09/18

Stephen Davis's recent trades

Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$193.6K
11,427 sh
$193.6K
Filed 24/05/03
Traded 24/05/02
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$316.6K
17,716 sh
$316.6K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$158.3K
8,858 sh
$158.3K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$317.1K
17,714 sh
$317.1K
Filed 24/03/27
Traded 24/03/27
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$137.6K
5,577 sh
$137.6K
Filed 24/02/27
Traded 24/02/26